304. Hepatocellular Carcinoma Occurs Frequently and Early After Treatment in HCV Genotype 3 Infected Persons Treated with DAA Regimens

BACKGROUND: Treatment of HCV with directly acting antiviral agents (DAAs) is associated with a significant reduction in cardiovascular, metabolic and cancer risk. However, there are conflicting data regarding the risk of hepatocellular carcinoma (HCC) after DAA treatment. Risk of HCC in HCV genotype...

Descripción completa

Detalles Bibliográficos
Autores principales: Un Nabi Tayyab, Ghias, Rasool, Shafqat, Nasir, Bilal, Butt, Adeel A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809789/
http://dx.doi.org/10.1093/ofid/ofz360.377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809789/
http://dx.doi.org/10.1093/ofid/ofz360.377

Ejemplares similares